Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.42 Million GBP | -20.02% |
| 2022 | 19.28 Million GBP | -16.2% |
| 2021 | 23.01 Million GBP | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 17.07 Million GBP | -11.5% |
| 2023 Q2 | 17.07 Million GBP | 0.0% |
| 2023 FY | 15.42 Million GBP | -20.02% |
| 2023 Q3 | 15.42 Million GBP | -9.62% |
| 2023 Q4 | 15.42 Million GBP | 0.0% |
| 2022 Q2 | 22.01 Million GBP | 0.0% |
| 2022 FY | 19.28 Million GBP | -16.2% |
| 2022 Q4 | 19.28 Million GBP | 0.0% |
| 2022 Q3 | 19.28 Million GBP | -12.38% |
| 2022 Q1 | 22.01 Million GBP | 0.0% |
| 2021 Q2 | 24.73 Million GBP | 0.0% |
| 2021 FY | 23.01 Million GBP | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 10.55 Million USD | -46.182% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -687.871% |
| CSL Limited | 38.02 Billion USD | 99.959% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 88.152% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4262.912% |
| BioStem Technologies, Inc. | 14.56 Million USD | -5.959% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 70.725% |
| Qrons Inc. | 420.00 USD | -3673233.333% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -2694.32% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 44.79% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 48.599% |
| Skye Bioscience, Inc. | 11.94 Million USD | -29.208% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -3110.441% |
| Rebus Holdings, Inc. | 5000.00 USD | -308460.0% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -2144.118% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -667778.788% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.544% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -1901.962% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 60.285% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -113.691% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -20105.883% |
| SQZ Biotechnologies Company | 107.18 Million USD | 85.606% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -977.35% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -21219.699% |
| Mesoblast Limited | 667.9 Million USD | 97.69% |
| Marizyme, Inc. | 22.01 Million USD | 29.921% |
| Genus plc | 1.02 Billion USD | 98.501% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -1035.787% |
| Pharming Group N.V. | 462.85 Million USD | 96.667% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -365.679% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -2991.542% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -2360.606% |
| ContraFect Corporation | 20.67 Million USD | 25.393% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -3852.188% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -3936.873% |
| IMV Inc. | 31.33 Million USD | 50.762% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -272.116% |
| MultiCell Technologies, Inc. | 126.22 USD | -12223002.519% |
| ONE Bio Corp. | 70.08 Million USD | 77.987% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -1541.82% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 87.995% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -3473.662% |
| Q BioMed Inc. | 3.51 Million USD | -338.854% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 56.144% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -5804.844% |
| Biomind Labs Inc. | 73.81 Thousand USD | -20799.768% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 96.543% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -964.85% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -461.767% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -492.656% |
| GB Sciences, Inc. | 103.44 Thousand USD | -14814.638% |
| Alpha Cognition Inc. | 2.45 Million USD | -529.157% |
| HST Global, Inc. | 1526.00 USD | -1010909.174% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1461.591% |
| Halberd Corporation | 10.13 Thousand USD | -152185.066% |
| Enzolytics Inc. | 361.7 Million USD | 95.735% |
| Agentix Corp. | 261.39 Thousand USD | -5802.246% |
| Resverlogix Corp. | 8.11 Million USD | -90.117% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -721.565% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.66% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 67.658% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -2311.921% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -67623.103% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -72.396% |
| AVAX Technologies, Inc. | 7.37 Million USD | -109.132% |
| Zenith Capital Corp. | 7410.00 USD | -208105.128% |
| Ember Therapeutics, Inc. | 184.00 USD | -8384682.609% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -4694.193% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -5802.879% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1562.57% |
| Kadimastem Ltd | 2.3 Million USD | -569.595% |
| Helix BioMedix, Inc. | 3.02 Million USD | -410.002% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -26922.104% |
| LadRx Corporation | 2.3 Million USD | -568.492% |
| Cell Source, Inc. | 195.17 Thousand USD | -7804.863% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4262.912% |
| NovAccess Global Inc. | 62.24 Thousand USD | -24684.732% |
| Affymax, Inc. | 7.44 Million USD | -107.282% |
| Itoco Inc. | 1.4 Million USD | -1001.943% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -16028.459% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -14454.717% |
| Mobile Lads Corp. | 52.00 USD | -29669130.769% |
| CytoDyn Inc. | 11.13 Million USD | -38.542% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -10690.924% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -86186.353% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -3902.376% |
| SYBLEU INC | 330.46 Thousand USD | -4568.531% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -3668.239% |
| International Stem Cell Corporation | 5.39 Million USD | -186.234% |
| Bioxytran, Inc. | 137.63 Thousand USD | -11109.114% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -2.841% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 6.943% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -19429.114% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -1684.25% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -105.241% |
| Neutra Corp. | 2851.00 USD | -541043.458% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 52.392% |
| PureTech Health plc | 693.97 Million USD | 97.777% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -91.151% |
| IXICO plc | 15.84 Million USD | 2.625% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -86.284% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 85.068% |
| CSL Limited | 38.02 Billion USD | 99.959% |
| Cellectis S.A. | 333.99 Million USD | 95.381% |